19910520
 SmithKline Unit Gets Approval for Tagamet for Another Disorder   The Wall Street Journal,  May 21, 1991  SmithKline Beecham Pharmaceuticals, a unit of SmithKline Beecham PLC, said it received FDA approval to market its ulcer drug Tagamet to treat lesions from another stomach disorder.   
